What are Brexit contingency plans for pharmaceutical industry?

What are Brexit contingency plans for pharmaceutical industry?

Brexit poses a large risk to pharmaceutical analysis and production in the United Kingdom, the trade has warned, via riding up production prices and deterring long term funding. AstraZeneca and different firms have frozen all production investments. Britain’s second-biggest drugmaker made up our minds to halt additional investments at its …

Read More »